# BP101 for Adults With Female Sexual Dysfunction

> **NCT03463707** · PHASE3 · COMPLETED · sponsor: **Ivix LLX** · enrollment: 205 (actual)

## Conditions studied

- Hypoactive Sexual Desire Disorder
- Female Sexual Dysfunction
- Sexual Desire Disorder

## Interventions

- **DRUG:** BP101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03463707
- **Lead sponsor:** Ivix LLX
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-05
- **Primary completion:** 2018-11-26
- **Final completion:** 2019-01-23
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2020-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03463707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03463707, "BP101 for Adults With Female Sexual Dysfunction". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03463707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*